Skip to main content
Livermore
Livermore
ZHEN

Advisor Group Holdings, Inc.

SEC CIK
0001677044
Latest filing
Aug 14, 2026

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Advisor Group Holdings, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overviewAll 13F holders of APLSFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of APLS by Advisor Group Holdings, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−2,615−100.0%Sold outHolders
Q1 20262,615$105.2K<0.1%−115−4.2%ReducedHolders
Q4 20252,730$68.6K<0.1%−424−13.4%ReducedHolders
Q3 20253,154$80.0K<0.1%+472+17.6%AddedHolders
Q2 20252,682$46.6K<0.1%+1,570+141.2%AddedHolders
Q1 20251,112$24.3K<0.1%−233−17.3%ReducedHolders
Q4 20241,345$36.8K<0.1%−769−36.4%ReducedHolders
Q3 20242,114$61.0K<0.1%−158−7.0%ReducedHolders
Q2 20242,272$87.2K<0.1%−729−24.3%ReducedHolders
Q1 20243,001$176.4K<0.1%−2,990−49.9%ReducedHolders
Q4 20235,991$358.6K<0.1%−60−1.0%ReducedHolders
Q3 20236,051$230.1K<0.1%+1,082+21.8%AddedHolders
Q2 20234,969$452.4K<0.1%−9,268−65.1%ReducedHolders
Q1 202314,237$938.8K<0.1%+10,988+338.2%AddedHolders
Q4 20223,249$166.6K<0.1%+209+6.9%AddedHolders
Q3 20223,040$209.0K<0.1%+373+14.0%AddedHolders
Q2 20222,667$120.0K<0.1%+62+2.4%AddedHolders
Q1 20222,605$132.0K<0.1%−741−22.1%ReducedHolders
Q4 20213,346$158.0K<0.1%−655−16.4%ReducedHolders
Q3 20214,001$132.0K<0.1%+1,788+80.8%AddedHolders
Q2 20212,213$139.0K<0.1%+7+0.3%AddedHolders
Q1 20212,206$95.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.